LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Novartis is proud to support the EuropaBio 25th Anniversary

14/06/2021
PRESS RELEASE

Novartis is proud to support the EuropaBio 25th Anniversary

Brussels, Belgium – 14 June 2021 – EuropaBio today announced that Novartis, the Swiss pharma company, has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor.

Novartis, which itself celebrates 25 years since its creation through the merger of Ciba-Geigy and Sandoz in 1996, has the purpose of reimagining medicine to improve and extend people's lives, using innovative science and technology. As part of the anniversary, EuropaBio and Novartis will bring a focus to the journey of healthcare into sustainability as the world addresses climate change.

“The combination of our own 25th anniversary with that of EuropaBio is an excellent opportunity to show the very best of biotechnology and its positive impact on patients.” commented Andrew Topen, Head of European Public Affairs for Novartis.

During 2021, EuropaBio, together with its members and partners, will nominate the most impactful cross-sector developments from the last quarter-century and showcase how they have benefitted society and the environment. The year’s programme of celebratory events will end in December with a gala evening in Brussels and the presenting of the 2021 SME Award from EuropaBio.

Dr Claire Skentelbery, Director General of EuropaBio commented, “We are absolutely delighted to welcome Novartis to the anniversary as a sponsor. Their own dedication to progress in healthcare through biotechnology really shows how this technology holds the key for healthy citizens worldwide.”

Join in the EuropaBio anniversary celebrations for the whole of 2021 through our newsletter and visit the dedicated Anniversary website at www.europabio25.org.

Download the full PRESS RELEASE below.

Novartis supports the EuropaBio 25th Anniversary in 2021


Download
2021_06_G_PR_Novartis-Sponsor-for-EuropaBio-25th-AnniversaryDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.